ADC Therapeutics Stock Forecast

Stock Price Forecast

According to 5 analysts polled by S&P Global, ADC Therapeutics stock has a consensus rating of "Buy" and an average price target of $5.00. The average 1-year stock price forecast is 358.72% higher than the current stock price, while the lowest is $2.00 (+83.49%) and the highest is $10 (+817.43%).

Price Target: $5.00 (+358.72%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$2.00	$5.00	$3.00	$10
Change	+83.49%	+358.72%	+175.23%	+817.43%

Analyst Ratings

The average analyst rating for ADC Therapeutics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Jan '26	Feb '26	Mar '26	Apr '26	May '26	Jun '26
Strong Buy	5	5	5	5	5	3
Buy	1	1	1	1	1	0
Hold	0	0	0	0	0	2
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	6	6	6	6	6	5

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Robert Burns H.C. Wainwright	H.C. Wainwright	Hold Downgrades n/a	Hold	Downgrades	n/a	n/a	Jun 8, 2026
Michael Schmidt Guggenheim	Guggenheim	Buy Maintains $10	Buy	Maintains	$10	+817.43%	Jun 5, 2026
Sudan Loganathan Stephens	Stephens	Buy Reiterates $5	Buy	Reiterates	$5	+358.72%	Jun 4, 2026
Leonid Timashev RBC Capital	RBC Capital	Hold Downgrades $6 → $2	Hold	Downgrades	$6 → $2	+83.49%	Jun 4, 2026

Financial Forecast

Revenue This Year

81.46M

from 81.36M

0.13%

from 81.36M

Revenue Next Year

124.04M

from 81.46M

52.27%

from 81.46M

EPS This Year

1.02

from -

EPS Next Year

2.27

from 1.02

122.55%

from 1.02

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	33.92M	209.91M	69.56M	70.84M	81.36M	81.46M
Revenue Growth	-	518.89%	-66.86%	1.84%	14.85%	0.13%
Gross Profit	-125.48M	20.15M	-60.10M	-43.23M	-26.16M	66.80M
Gross Margin	-369.96%	9.60%	-86.40%	-61.02%	-32.16%	82.00%
Operating Income	-261.72M	-123.34M	-165.99M	-129.14M	-106.10M	-94.54M
Net Income	-230.03M	-157.13M	-240.05M	-157.85M	-142.62M	-135.68M
EPS	-	-	-	-	-	1.02
Forward PE	-	-	-	-	-	1.07
Free Cash Flow	-141.90M	-72.93M	-79.93M	-70.85M	-103.81M	-166.00M
No. Analysts	-	-	-	-	-	5

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue	2026	2027	2028
High	88.1M
Avg	81.5M
Low	73.4M

Revenue Growth

Revenue Growth	2026	2027	2028
High	8.3%
Avg	0.1%
Low	-9.8%

EPS Forecast

EPS	2026	2027	2028
High	1.02
Avg	1.02
Low	1.02

EPS Growth

EPS Growth	2027	2028
High	122.5%
Avg	122.5%
Low	122.5%